New malaria vaccine shows 77% efficacy in trial, becoming first to surpass WHO target ...News

Russia Today - News
New malaria vaccine shows 77% efficacy in trial, becoming first to surpass WHO target
Researchers behind a novel malaria vaccine have reported that it’s up to 77% effective against the disease, which claims over 400,000 lives a year, making it the first inoculation to meet the WHO's target efficacy. The results of second-phase trials of the vaccine, known as R21 / Matrix-M and developed by the University of Oxford in cooperation with pharmaceutical giant Novax, were published in Preprints with The Lancet earlier this week. The researchers claim that the immunization has proven effective in a trial that involved 450 children aged between five and 17 months from Burkina Faso. The subjects were divided into three groups: t

Hence then, the article about new malaria vaccine shows 77 efficacy in trial becoming first to surpass who target was published today ( ) and is available on Russia Today ( News ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( New malaria vaccine shows 77% efficacy in trial, becoming first to surpass WHO target )

Apple Storegoogle play

Last updated :

Also on site :